Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy.
Krystel-Whittemore M, Xu J, Brogi E, Ventura K, Patil S, Ross DS, Dang C, Robson M, Norton L, Morrow M, Wen HY. Krystel-Whittemore M, et al. Among authors: ventura k. Breast Cancer Res Treat. 2019 Aug;177(1):61-66. doi: 10.1007/s10549-019-05295-9. Epub 2019 May 29. Breast Cancer Res Treat. 2019. PMID: 31144151 Free PMC article.
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2/CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0.
Hoda RS, Brogi E, Xu J, Ventura K, Ross DS, Dang C, Robson M, Norton L, Morrow M, Wen HY. Hoda RS, et al. Among authors: ventura k. Arch Pathol Lab Med. 2020 May;144(5):597-601. doi: 10.5858/arpa.2019-0307-OA. Epub 2019 Oct 24. Arch Pathol Lab Med. 2020. PMID: 31647316 Free article.
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Hoda RS, Brogi E, Dos Anjos CH, Grabenstetter A, Ventura K, Patil S, Selenica P, Weigelt B, Reis-Filho JS, Traina T, Robson M, Norton L, Wen HY. Hoda RS, et al. Among authors: ventura k. Mod Pathol. 2020 Nov;33(11):2221-2232. doi: 10.1038/s41379-020-0606-0. Epub 2020 Jul 1. Mod Pathol. 2020. PMID: 32612248 Free PMC article.
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Schwartz CJ, Brogi E, Marra A, Da Cruz Paula AF, Nanjangud GJ, da Silva EM, Patil S, Shah S, Ventura K, Razavi P, Norton L, D'alfonso T, Weigelt B, Pareja F, Reis-Filho JS, Wen HY. Schwartz CJ, et al. Among authors: ventura k. Mod Pathol. 2022 Feb;35(2):193-201. doi: 10.1038/s41379-021-00931-6. Epub 2021 Oct 1. Mod Pathol. 2022. PMID: 34599282 Free PMC article.
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.
Febres-Aldana CA, Chang JC, Ptashkin R, Wang Y, Gedvilaite E, Baine MK, Travis WD, Ventura K, Bodd F, Yu HA, Quintanal-Villalonga A, Lai WV, Egger JV, Offin M, Ladanyi M, Rudin CM, Rekhtman N. Febres-Aldana CA, et al. Among authors: ventura k. Clin Cancer Res. 2022 Nov 1;28(21):4702-4713. doi: 10.1158/1078-0432.CCR-22-1115. Clin Cancer Res. 2022. PMID: 35792876 Free PMC article.
Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
Savari O, Febres-Aldana C, Chang JC, Fanaroff RE, Ventura K, Bodd F, Paik P, Vundavalli M, Saqi A, Askin FB, Travis WD, Rekhtman N. Savari O, et al. Among authors: ventura k. Histopathology. 2023 Jan;82(2):242-253. doi: 10.1111/his.14801. Epub 2022 Oct 20. Histopathology. 2023. PMID: 36130728 Free PMC article.
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.
Vanguri RS, Luo J, Aukerman AT, Egger JV, Fong CJ, Horvat N, Pagano A, Araujo-Filho JAB, Geneslaw L, Rizvi H, Sosa R, Boehm KM, Yang SR, Bodd FM, Ventura K, Hollmann TJ, Ginsberg MS, Gao J; MSK MIND Consortium; Hellmann MD, Sauter JL, Shah SP. Vanguri RS, et al. Among authors: ventura k. Nat Cancer. 2022 Oct;3(10):1151-1164. doi: 10.1038/s43018-022-00416-8. Epub 2022 Aug 29. Nat Cancer. 2022. PMID: 36038778 Free PMC article.
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.
Offin M, Sauter JL, Tischfield SE, Egger JV, Chavan S, Shah NS, Manoj P, Ventura K, Allaj V, de Stanchina E, Travis W, Ladanyi M, Rimner A, Rusch VW, Adusumilli PS, Poirier JT, Zauderer MG, Rudin CM, Sen T. Offin M, et al. Among authors: ventura k. Genome Med. 2022 Nov 15;14(1):127. doi: 10.1186/s13073-022-01129-4. Genome Med. 2022. PMID: 36380343 Free PMC article.
95 results